Navigation Links
Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
Date:10/21/2007

rmation and statements. These risks and uncertainties include those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2006. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements.

References:

1 Guidelines for Management of Acute Coronary Syndrome without Persistent

ST segment Elevation (JCS 2002, Circulation Journal Vol.66, Suppl. IV.

2002, pp.1123-1163)

2 Guidelines for management of anticoagulant and antiplatelet therapy in

cardiovascular disease (JCS 2004, Circulation Journal Vol.68, Suppl. IV,

2004, pp.1153-1219)

3 The American College of Cardiology/The American Heart Association

4 ACC/AHA 2007 Guidelines for the Management of Patients With Unstable

Angina/Non-ST-Elevation Myocardial Infarction: Circulation 116: 803 -

877, 2007

5 The American College of Cardiology/The American Heart Association/The

Society of Cardiovascular Angiography and Interventions

6 ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary

Intervention: Circulation 113(7): e166 - e286, 2006

7 The European Society of Cardiology

8 Guidelines for the diagnosis and treatment of non-ST-segment elevation

acute coronary syndromes: Eur Heart J. 28(13): 1598-1660, 2007


'/>"/>
SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Othera Pharmaceuticals Announces Upcoming Presentation Based Upon Expanded Understanding of Lead Compound Mechanism of Action
2. Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan
3. First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study Demonstrates Significant Reduction in Blood Pressure and Protection of Organs with Valsartan
4. LANI completes Phase I in Japan and to commence Phase I in UK
5. AEterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
6. New Data from the US and Japan Support: No Established Causal Link Between Neuropsychiatric Symptoms and Treatment with Tamiflu US Databases Indicate Psychiatric Symptoms Lower in Influenza Patients Taking Tamiflu Versus Those Not Taking Tamiflu
7. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Calif. , May 4, 2015 Unchained ... coming out to this year,s PEGS conference and launches ... stability system for biologics. PEGS: The Essential Protein Engineering ... May 4-8, 2015. The UNit lets drug ... any other tool out there. Its 7 applications, 144 ...
(Date:5/4/2015)... newest member of the cuvette manufacturing world, opened their doors to the public in ... head by offering scientists amazing support for their spectroscopy needs.  ... ... ... In mid-2014 ...
(Date:5/4/2015)... CONCORD, N.H. , May 4, 2015 /PRNewswire/ ... creating analytic and technology solutions to improve healthcare ... Bedford Nursing & Rehabilitation Center (BNRC) use ... monitoring platform to improve the quality and lower ... analytics platform integrates clinical, outcomes, claims and utilization ...
Breaking Medicine Technology:Unchained Labs Lets the UNit Loose 2New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 2New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 3Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 2Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 3
... , HOUSTON, Oct. 5 PAC, a leading global ... process applications, announces the introduction of the ANTEK MultiTek(TM) ... sulfur , nitrogen, and halides. Industries include ... Pharmaceutical, Environmental, and many more. , "MultiTek(TM) is ...
... , SAN DIEGO, Oct. 2 Pharmatek Laboratories, Inc., ... pharmaceutical industry, announced that it is the first CRO ... enhancing the company,s preclinical and early phase clinical GMP ... to move our customers, drug candidates into the clinic ...
Cached Medicine Technology:New ANTEK MultiTek(TM) by PAC Provides Fast, All-in-One Testing for Sulfur, Nitrogen, Halides 2Pharmatek Laboratories Announces Acquisition of the First Xcelodose(R) 600S System on the West Coast 2
(Date:5/4/2015)... Charlottesville, VA (PRWEB) May 04, 2015 Ticket ... tickets at the John Paul Jones Arena in Charlottesville, ... in the history of the music business and this beloved ... down. Paul McCartney, the former member of two legendary groups: ... decades in the music business since 2013 on the “Out ...
(Date:5/4/2015)... SC (PRWEB) May 04, 2015 Ticket Down ... at the Colonial Life Arena in Columbia, South Carolina. ... the continuation of his “Out There” tour which originally kicked ... long tour is North America and the legendary performer recently ... at the Wells Fargo Arena on June 21st, in Charlottesville, ...
(Date:5/4/2015)... May 04, 2015 New findings released ... Tumor Association (ABTA) show that people diagnosed with a ... treatment options, including clinical trials, at the time of ... make difficult decisions about their course of treatment. The ... the first nationwide brain tumor volunteer network, the ABTA ...
(Date:5/4/2015)... Greensboro, NC (PRWEB) May 04, 2015 ... excited to offer this unique program to other leadership ... create valuable ties between CCL and successful practitioners, expanding ... organizations around the globe,” said John R. Ryan, CCL ... consultancy joins the CCL Partner Network , it ...
(Date:5/4/2015)... American Fork, UT (PRWEB) May 04, 2015 ... the surgery (up to $3,000) of one patient receiving care ... corner of Utah. The procedure must be performed by ... customer (willing to pay in full up front and forego ... the U.S. becomes more economically burdensome every year, and it ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:The Center for Creative Leadership Is Partnering with Lead Star to Create the CCL Partner Network 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3
... ... the 62nd Annual Conference of the Society for Human Resources Management (SHRM). During the ... integration to Human Resource and Payroll professionals at Booth #531 , ... Monterey Park, Calif. (Vocus) June 25, ...
... wine, grapes, blueberries, peanuts and other plants stops ... vision researchers at Washington University School of Medicine in ... vision in blinding eye diseases such as diabetic retinopathy ... in Americans over 50. The formation of new ...
... ... first patent pending method that allows for significant risk reduction for index ... the losses significantly limited or capped while reinvesting index gains accrued to ... Effect." Between 95-100% of the principal value is invested and backed by ...
... ... Values While Creating an Engaged Workforce, , ... Charlotte, NC (Vocus) June 24, 2010 -- ... “Managing the Paradox of Employee Alignment and Engagement.” The free hour-long webinar ...
... HealthDay Reporter , THURSDAY, June 24 (HealthDay News) ... the risk of invasive breast cancer by around 30 ... is considering bisphosphonate use for bone, this might be ... clinical oncologist at the Los Angeles Biomedical Research Institute ...
... trial of a novel radioactive compound readily and safely ... volunteers on brain scans and opens the doors to ... their own radioactive compounds. The results, reported by a ... Nuclear Medicine, could lead to better ways to ...
Cached Medicine News:Health News:NOVAtime participates in the Society for Human Resources Management, (SHRM) 62nd Annual Conference in San Diego, California between June 27 and June 29, 2010 2Health News:NOVAtime participates in the Society for Human Resources Management, (SHRM) 62nd Annual Conference in San Diego, California between June 27 and June 29, 2010 3Health News:Ingredient in red wine may prevent some blinding diseases 2Health News:Ingredient in red wine may prevent some blinding diseases 3Health News:Principal Protected Index Investing Provides Innovative Method to Significantly Reduce Stock Market Loss and Risk 2Health News:Principal Protected Index Investing Provides Innovative Method to Significantly Reduce Stock Market Loss and Risk 3Health News:Morehead Presents Webinar on “Managing the Paradox of Employee Alignment and Engagement”, 2Health News:Bone-Building Pills Appear to Lower Invasive Breast Cancer Risk 2Health News:Bone-Building Pills Appear to Lower Invasive Breast Cancer Risk 3Health News:Novel radiotracer shines new light on the brains of Alzheimer's disease patients 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: